Wesana Health Holdings Inc. (WSNAF) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Chicago, IL, United States. The current CEO is Daniel Carcillo.
WSNAF has IPO date of 2021-06-04, 7 full-time employees, listed on the Other OTC, a market capitalization of $341K.
Wesana Health Holdings Inc, a life sciences company, engages in the development and delivery of psychedelic medicines and psilocybin-assisted psychotherapies to treat traumatic brain injuries. It is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma. The company is based in Chicago, Illinois.
